Navigation Links
New robot-assisted surgical method found successful for treatment of thyroid cancer
Date:8/19/2009

CHICAGO (August 19, 2009) Using a novel robot-assisted endoscopic technique, a team of surgeons at Yonsei University College of Medicine in Seoul, Korea, has successfully treated 200 consecutive patients with thyroid cancer. The minimally invasive operation, which has several technical and cosmetic benefits that the traditional open operation does not offer, is described in the August issue of the Journal of the American College of Surgeons.

According to the National Cancer Institute, more than 37,000 people are diagnosed with thyroid cancer each year in the United States. Surgical removal of all or part of the thyroid gland the most common treatment for thyroid cancer typically requires a three- to five-inch incision across the front of the neck. Although robot-assisted endoscopic operations have been adopted in the surgical treatment of various cancers, the incorporation of these techniques has been delayed in head and neck surgery due to the narrow, deep anatomical space and delicate nerves and blood vessels in these areas.

The use of robots provides surgeons with a three-dimensional view and enhanced magnification of the anatomy, as well as the ability to filter unintentional movements of human hands, enabling a safer and easier operation that preserves structures surrounding the target organ.

"This innovative robot-assisted technique for thyroid surgery represents an exciting new treatment option for patients with thyroid cancer," said Woong Youn Chung, MD, PhD, Yonsei University College of Medicine in Seoul. "Not only does it offer good clinical outcomes, but it also spares patients from the large, visible scar that results from traditional open surgery."

Over a 10-month period, a surgical team at Yonsei University College of Medicine operated on 200 patients (mean age 40.3 9.5 years) with thyroid cancer by robot-assisted endoscopic thyroidectomy using a novel transaxillary approach. All patients had well-differentiated, local thyroid tumors of at least two centimeters. Using the da Vinci Surgical System (Intuitive Surgical), a surgeon removed all or part of the thyroid gland by making an incision under the patient's right arm (in the patient's lesion-side axilla), eliminating the need for a neck incision.

After the operation, all patients underwent neck ultrasonography and serum thyroglobulin tests at three- and six-month intervals. Of the 45 patients who had a bilateral total thyroidectomy, 38 received radioactive iodine (RAI) therapy between four and six weeks postoperatively and a body scan two days later to investigate possible abnormal radiation uptake. Seven low-risk patients did not undergo RAI.

In this study, postoperative complications included transient low calcium levels (hypocalcemia) in 12 patients (26.7 percent), transient hoarseness in 8 patients (4 percent) and permanent nerve paralysis in one patient (0.5 percent). Serum parathyroid hormone levels were slightly reduced during the immediate postoperative period but normalized within one month of the operation.

In the patients who underwent bilateral total thyroidectomy, serum thyroglobulin was less than one nanogram per milliliter in 42 patients (93.3 percent). No tumor recurrence was observed by neck ultrasonography at 10 and 18 months postoperatively, and no patient was found to have abnormal radiation uptake.


'/>"/>

Contact: Sally Garneski
pressinquiry@facs.org
312-202-5409
Weber Shandwick Worldwide
Source:Eurekalert

Related medicine news :

1. Canonsburg Woman Undergoes Robot-Assisted Weight Loss Procedure at AGH
2. Fox Chase performs the world’s first successful ViKY robot-assisted surgery for pancreatic tumors
3. Urologists report success using robot-assisted surgery for urinary abnormality
4. Robot-assisted minimally-invasive CABG surgery
5. Surgical Care Affiliates and Hawaii Pacific Health Partners, Inc. Complete Joint Venture
6. Nonsurgical Technique Can Take Years Off the Appearance of Aging Eyes
7. Interventional radiology treatment for uterine fibroids: Safe, nonsurgical option
8. Interventional Radiology Treatment for Uterine Fibroids: Safe, Nonsurgical Option
9. Twin Cities Orthopedics to Partner with Surgical Care Affiliates
10. Surgical Care Affiliates Announces Investor Conference Call to Discuss 2009 Second Quarter Results
11. Germgards New Room-Temperature Surgical Instrument Sterilizer Achieves Total Cycle Time of Three Minutes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: